The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID‐19 Patients: A Retrospective Cohort Study

Published:2020-10-15 Issue:6 Volume:13 Page:1087-1095
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Shi Chen¹²,Wang Cong¹,Wang Hanxiang¹,Yang Chao³,Cai Fei³,Zeng Fang¹,Cheng Fang¹,Liu Yihui¹,Zhou Taotao¹,Deng Bin¹,Vlodavsky Israel⁴,Li Jin‐Ping⁵,Zhang Yu¹²

Affiliation:

1. Department of Pharmacy Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

2. Hubei Province Clinical Research Center for Precision Medicine for Critical Illness Wuhan China

3. Department of Vascular Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

4. Technion Integrated Cancer Center Rappaport Faculty of Medicine Technion Israel

5. Department of Medical Biochemistry and Microbiology Uppsala University Uppsala Sweden

Funder

Research and Development

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12880

Reference39 articles.

1. A novel coronavirus outbreak of global health concern

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

3. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia

4. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

5. IL-19 Induces Production of IL-6 and TNF-α and Results in Cell Apoptosis Through TNF-α

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Overview of the current procedures in synthesis of heparin saccharides;Carbohydrate Polymers;2024-09

3. Efficacy of therapeutic-dose heparin for severe COVID-19 patients at COVID-19 Emergency Hospital Jakarta;The Journal of Infection in Developing Countries;2024-07-29

4. Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro;Inflammopharmacology;2024-07-24

5. Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity;2024-07-09